Advanced Pancreatic Cancer: Flourishing Novel Approaches in the Era of Biological Therapy

The progress in the development of systemic treatment for advanced pancreatic cancer (APC) has been slow. The mainstream treatment remains using chemotherapy including gemcitabine, FOLFIRINOX, and nab-paclitaxel. Erlotinib is the only approved biological therapy with marginal benefit. Studies of age...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Chiu, Joanne W., Wong, Hilda, Leung, Roland, Pang, Roberta, Cheung, Tan-To, Fan, Sheung-Tat, Poon, Ronnie, Yau, Thomas
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2014
Onderwerpen:
Gastrointestinal Cancer
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153449/
https://ncbi.nlm.nih.gov/pubmed/25117068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0131
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items